Skip to content

Prognostic value of a clinical algorithm based on neutrophil-to-lymphocyte ratio in the severe acute cholangitis: an observational study

Prognostic value of a clinical algorithm based on neutrophil-to-lymphocyte ratio in the severe acute cholangitis: an observational study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036570
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe acute cholangitis

Interventions

Gold Standard:Clinical outcome
Index test:A&#32
prediction&#32
model&#32
based&#32
on&#32
in&#32
the&#32
cholangitis.

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients with acute cholangitis, diagnostic criteria: 1. Systemic inflammation: (1) Fever and/or shaking chills; (2) Laboratory data: evidence of inflammatory response 2. Cholestasis: (1) Jaundice; (2) Laboratory data: abnormal liver function tests; 3. Imaging: (1) Biliary dilatation; (2) Evidence of the etiology on imaging (stricture, stone, stent etc.); Definite diagnosis: one item in 1, one item in 2 and one item in 3.

Exclusion criteria

Exclusion criteria: 1. Patients with liver cirrhosis; 2. Patients in chemotherapy; 3. Patients taking anticoagulants; 4. Patients with renal failure; 5. Patients with respiratory failure.

Design outcomes

Primary

MeasureTime frame
NLR;SEN, SPE, ACC, AUC of ROC;

Secondary

MeasureTime frame
CRP;total bilirubin;AST;White blood cell count;D-Dimer;Blood lipid routine;platelet count;

Countries

China

Contacts

Public ContactYinshi Huang

Department of Gastroenterology, Shanghai General Hospital

13681702140@163.com+86 13681702140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026